Amgen amends Prolia offer

While discounts may provide more incentive for pharmacies to sign up, the Guild says it will continue to oppose exclusive direct supply despite attempts to “embellish” it Following its November decision to provide Prolia (denosumab) via exclusive direct supply, Amgen has this week announced an update to its commercial offer. Amgen is now offering: Second